Skip to Main Content

Paper Details

High <i>NPM1</i>-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.
Blood
62
2018
AML, Acute myeloid leukemia, DNMT3A, FLT3, NPM1, NPM1 mutation, NPM1-mutant, mutant allele, mutated allele, patient, patients, stem-cell
Author NameAffiliation
Frank C KuoBrigham and Women's Hospital
Christopher J GibsonDana-Farber Cancer Institute
David P SteensmaDana-Farber Cancer Institute
Timothy A GraubertMassachusetts General Hospital Cancer Center
Richard M StoneDana-Farber Cancer Institute
Daniel J DeAngeloDana-Farber Cancer Institute
  • 1 - 6

Datasets

Release 1.2